Four-year follow-up of patients with chronic-phase chronic myeloid leukemia
receiving 100 mg of dasatinib once daily.
However, its association with chondroid syringoma and chronic myeloid leukemia
Five-year follow up of patients receiving imatinib for chronic myeloid leukemia
," The New England Journal of Medicine, vol.
Table 1: The evaluation of chronic myeloid leukemia
based on age in year, sex, socioeconomic status and Clinico laboratory findings.
Chronic myeloid leukemia
in a man with myasthenia gravis treated by thymectomy.
Long-term survival estimates for imatinib versus interferon-alpha plus lows-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia
PharmaPoint: Chronic Myeloid Leukemia
(CML) - Spain Drug Forecast and Market Analysis to 2022
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia
after failure of imatinib therapy.
In this study, 22 patients with chronic myeloid leukemia
Regional physicians who treat Chronic Myeloid Leukemia
will receive the latest CML updates and share their patient treatment experiences.
Other potential indications include treatment of Philadelphia chromosome--positive acute lymphoblastic leukemia and lymphoid-blast chronic myeloid leukemia
in patients who did not respond to or could not tolerate prior therapy with imatinib (marketed by Novartis as Gleevec).
Juvenile xanthogranuloma, neurofibromatosis 1, and juvenile chronic myeloid leukemia